Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
28.31
-0.12 (-0.42%)
Mar 31, 2025, 10:13 AM EDT - Market open
Amphastar Pharmaceuticals Market Cap
Amphastar Pharmaceuticals has a market cap or net worth of $1.35 billion as of March 31, 2025. Its market cap has decreased by -35.60% in one year.
Market Cap
1.35B
Enterprise Value
1.78B
1-Year Change
-35.60%
Ranking
Category
Stock Price
$28.31
Market Cap Chart
Since June 25, 2014, Amphastar Pharmaceuticals's market cap has increased from $374.20M to $1.35B, an increase of 260.50%. That is a compound annual growth rate of 12.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.35B | -24.12% |
| Dec 31, 2024 | 1.79B | -39.75% |
| Dec 29, 2023 | 2.96B | 118.81% |
| Dec 30, 2022 | 1.35B | 21.52% |
| Dec 31, 2021 | 1.11B | 16.65% |
| Dec 31, 2020 | 955.30M | 5.51% |
| Dec 31, 2019 | 905.40M | -1.31% |
| Dec 31, 2018 | 917.40M | 3.71% |
| Dec 29, 2017 | 884.60M | 4.34% |
| Dec 30, 2016 | 847.80M | 32.34% |
| Dec 31, 2015 | 640.60M | 23.57% |
| Dec 31, 2014 | 518.40M | 38.54% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |